Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Human antigen R binding and regulation of SOX2 mRNA in human mesenchymal stem cells.
Retinal nerve fibre layer thinning in patients with clinically isolated optic neuritis and early treatment with interferon-Beta.
Optical coherence tomography as a biomarker in multiple sclerosis.
Confounding underlies the apparent 'month of birth' effect in multiple sclerosis.
Oligodendrocyte Precursor Cell-Intrinsic Effect of Rheb1 Controls Differentiation and Mediates mTORC1-Dependent Myelination in Brain.
The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients.
AAV1.NT-3 gene therapy for Charcot-Marie-Tooth neuropathy.
Failed, interrupted and inconclusive trials on relapsing multiple sclerosis treatment: update 2010-2015.
Multiple sclerosis: Characterization of lesion evolution in relapsing-remitting and secondary progressive multiple sclerosis.
Expression and isotopic labelling of the potassium channel blocker ShK toxin as a thioredoxin fusion protein in bacteria.
Extended-release dalfampridine in the management of multiple-sclerosis-related walking impairment.
Oxidative stress in multiple sclerosis patients in clinical remission: Association with the expanded disability status scale.
Hand dexterity and direct disease related cost in multiple sclerosis.
Mortality and Cause of Death in Multiple Sclerosis: Findings from a Prospective Population-Based Cohort in Bizkaia, Basque Country, Spain.
PERK Dependent Activation of JAK1 and STAT3 Contributes to ER Stress Induced Inflammation.
Cholesterol Modification of p40-Specific Small Interfering RNA Enables Therapeutic Targeting of Dendritic Cells.
Identification of suitable reference genes for peripheral blood mononuclear cell subset studies in multiple sclerosis.
Quality improvement and practice-based research in neurology using the electronic medical record.
Safety profile of dalfampridine extended release in multiple sclerosis: 5-year postmarketing experience in the United States.
Serial proton MR spectroscopy of gray and white matter in relapsing-remitting MS.
A case of prolonged delayed postdural puncture headache in a patient with multiple sclerosis exacerbated by air travel.
Reproduction and the risk of multiple sclerosis.
Increased Concentrations of Glutamate and Glutamine in Normal-Appearing White Matter of Patients with Multiple Sclerosis and Normal MR Imaging Brain Scans.
Patient and equipment profile for wheelchair seating clinic provision.
FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory.
Pages
« first
‹ previous
…
290
291
292
293
294
295
296
297
298
…
next ›
last »